Newark, DE, United States of America

Beverly K Folmer


Average Co-Inventor Count = 11.0

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1999-2005

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Beverly K. Folmer

Introduction

Beverly K. Folmer is a distinguished inventor based in Newark, Delaware, recognized for her significant contributions to the field of neuroscience. With a total of 10 patents to her name, Folmer's innovative work focuses primarily on developing methods and compounds that target critical health challenges, particularly Alzheimer's disease.

Latest Patents

Among her latest innovations, Folmer has disclosed groundbreaking patents related to "Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis." These patents detail compounds that effectively inhibit the release and synthesis of β-amyloid peptides, providing promising avenues for treating Alzheimer's disease. The documents also outline pharmaceutical compositions containing these compounds, along with methods for both prophylactic and therapeutic treatment against Alzheimer’s, enhancing hope for patients and healthcare providers alike.

Career Highlights

Beverly K. Folmer has demonstrated exceptional dedication and expertise during her career. She has been involved with prominent organizations, such as Athena Neurosciences, Inc. There, she has leveraged her knowledge and skills to drive innovations that aim to improve neurodegenerative disease management.

Collaborations

Throughout her career, Folmer has collaborated with notable individuals in the field, including James E. Audia and Lee H. Latimer. These partnerships have further enriched her research and expanded the impact of her inventions in medical science.

Conclusion

Beverly K. Folmer stands out as an influential inventor whose work is making a difference in the fight against Alzheimer's disease. With her extensive patent portfolio and collaborations within the industry, Folmer continues to pave the way for future innovations that may significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…